2016
DOI: 10.1016/j.pan.2016.08.009
|View full text |Cite
|
Sign up to set email alerts
|

The safety and benefit of pancreatic juice cytology under ERCP in IPMN patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
13
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 14 publications
(13 citation statements)
references
References 28 publications
0
13
0
Order By: Relevance
“…One potential drawback of ERCP assessment of pancreatic juice cytology, however, is post-ERCP pancreatitis (PEP). 75 Rates of PEP in patients diagnosed with BD-IPMN and MD-IPMN were 17.2% and 3.6%, respectively. 75 Another drawback of cytology by the transpapillary approach is the poor sensitivity of this method, despite its high specificity.…”
Section: Assessment Of Pancreatic Juice By a Transpapillary Approachmentioning
confidence: 89%
See 2 more Smart Citations
“…One potential drawback of ERCP assessment of pancreatic juice cytology, however, is post-ERCP pancreatitis (PEP). 75 Rates of PEP in patients diagnosed with BD-IPMN and MD-IPMN were 17.2% and 3.6%, respectively. 75 Another drawback of cytology by the transpapillary approach is the poor sensitivity of this method, despite its high specificity.…”
Section: Assessment Of Pancreatic Juice By a Transpapillary Approachmentioning
confidence: 89%
“…75 Rates of PEP in patients diagnosed with BD-IPMN and MD-IPMN were 17.2% and 3.6%, respectively. 75 Another drawback of cytology by the transpapillary approach is the poor sensitivity of this method, despite its high specificity. New methods, including immunohistochemical (IHC) analysis of markers, are warranted to improve diagnostic accuracy.…”
Section: Assessment Of Pancreatic Juice By a Transpapillary Approachmentioning
confidence: 89%
See 1 more Smart Citation
“…However, the rate of malignant IPMN in patients with HRS and WF were reported to be 49%-57% and 16%-27%, respectively. 2,3 Although the presence of mural nodules (MN) on endoscopic ultrasonography (EUS) has been shown to be a good predictor of malignant branch duct IPMN (BD-IPMN), [4][5][6][7][8][9][10] about 10% of malignant BD-IPMNs have been reported in patients without MN. 8,11,12 As mentioned above, the diagnostic ability of the imaging studies for malignant IPMN is limited.…”
Section: Ipmnmentioning
confidence: 99%
“…However, the sensitivity of PJC for malignant IPMN was found to be only 35% in a meta-analysis, 13 and the accuracy was also unsatisfactory (33%-64%). 2,[14][15] Furthermore, the incidence of post-ERCP pancreatitis (PEP) was also reported to be about 8%-25%. 2,[14][15][16] These are challenges that must be considered when performing PJC for the diagnosis of malignant IPMN.…”
Section: Introductionmentioning
confidence: 99%